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Background: The interaction between the C terminus of claudin proteins and the ZO-1 PDZ1 domain regulates tight
junction assembly.
Results: Solved structures of PDZ1 in complex with claudin-1 and claudin-2 and determined binding affinities.
Conclusion: Phosphorylation state of the tyrosine at position-6 regulates claudin/ZO-1 interaction.
Significance: Revealed how post-translational modifications could affect the claudin/ZO-1 interaction and thereby tight junc-
tion barrier properties.
The molecular seal between epithelial cells, called the tight
junction (TJ), is built by several membrane proteins, with clau-
dins playing the most prominent role. The scaffold proteins of
the zonula occludens family are required for the correct local-
ization of claudins and hence formation of the TJ. The intracel-
lular C terminus of claudins binds to the N-terminal PDZ
domain of zonula occludens proteins (PDZ1). Of the 23 identi-
fied human claudin proteins, nine possess a tyrosine at the 6
position. Here we show that the claudin affinity for PDZ1 is
dependent on the presence or absence of this tyrosine and that
the affinity is reduced if the tyrosine is modified by phosphory-
lation. The PDZ1 2-3 loop undergoes a significant conforma-
tional change to accommodate this tyrosine. Cell culture exper-
iments support a regulatory role for this tyrosine. Plasticity has
been recognized as a critical property of TJs that allow cell
remodeling and migration. Our work provides a molecular
framework for how TJ plasticity may be regulated.
Tight junctions create selective paracellular barriers between
epithelial cells limiting movement of material through the
intracellular space (1). The cell-cell junction seal is formed by
members of the claudin family. Claudins have four transmem-
brane domains; it is the extracellular loops connecting the
transmembrane domains that form the paracellular barrier.
The C-terminal cytoplasmic sequences of claudin bind to the
PDZ domains of several distinct scaffolding proteins. The most
fully characterized interaction is with PDZ domains of the
zonula occludens proteins ZO-1,3 ZO-2, and ZO-3 (2). This is a
critical interaction, as without it claudins do not localize to
build a tight junction (3). Although less well characterized,
claudins also interact with MUPP1 (multi-PDZ domain-con-
taining protein-1) (4) and Pals1-associated tight junction pro-
tein (PATJ)) (5) via PDZ-mediated interactions. Although most
of the 23 human claudins end in a similar Tyr-Val canonical
PDZ binding motif (see Fig. 1), their more upstream residues
are both shared and distinct (6). The mechanisms that regulate
claudin function remain poorly defined but of considerable
interest. Potentially their localization at the barrier, turnover,
trafficking, and selective barrier properties might be influenced
by the specificity and affinity of binding to cytoplasmic scaffold-
ing proteins, such as ZO-1. Furthermore, it seems reasonable to
speculate that the affinity of claudins for the PDZ domains of
the scaffolding proteins is dynamically regulated to allow
remodeling during cell-cell movements. This led us in the cur-
rent study to determine the structural determinants of specific-
ity and affinity for claudin binding to their PDZ target (PDZ1)
in ZO-1.
Because of the prevalence of PDZ domains and their role in
myriad cellular events, there has been considerable interest in
understanding the structural basis for this type of protein-pro-
tein interaction and whether these interactions are regulated
(7). Within the human genome alone there are 150 PDZ
domain-containing proteins, many with multiple PDZ domains
(8). The claudin-binder ZO-1, the focus of this work, contains
three tandem PDZ domains in its N terminus, and it is the first
PDZ domain (PDZ1) that binds claudins. The second (PDZ2)
binds connexins, which are gap junction proteins, showcasing
the diverse role of ZO-1 in cellular junctions. Interestingly,
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PDZ2 is also required for ZO-1 homo- and heterodimerization
with other ZO proteins via a unique domain-swapping mecha-
nism (9, 10). This dimerization is critical for normal tight junc-
tion barrier formation (11). Finally, the third ZO-1 PDZ domain
(PDZ3) binds the tight junction protein JAM-A (12). Thus,
ZO-1 can assemble multiprotein complexes with multiple junc-
tion proteins via its three PDZ domains. Here we examine in
detail the interaction between claudin-1 and -2 to PDZ1 of
ZO-1.
The first studies of claudin binding to ZO-1, which were
based on mutational deletions, suggested a requirement for the
C-terminal residue, position 0 (P0), and the residue at position
2 (P2) of the ligand for binding to its cognate PDZ-domain
(2). The accepted nomenclature used to refer to residues bind-
ing to PDZ domains is as follows. The C-terminal residue is
referred to as the P0 residue; subsequent residues toward the N
terminus are termed P1, P2, P3, etc. More recent studies
reveal a role for residues at positions P1, P3, P4, and P5 in
defining specificity (13). In the “general model” the claudin’s P0
hydrophobic side chain inserts into a hydrophobic pocket, and
the C-terminal carboxylate coordinates with a largely con-
served GLGF motif within the PDZ domain (7). The preceding
several residues build an antiparallel strand to the 2 strand of
the PDZ domain. In contrast to specificity, not much is known
about what determines the interaction affinity. Most reported
affinities are relatively low and in the micromolar range (14).
However, the implication of evidence in several studies is that
phosphorylation of claudins near their PDZ binding motifs
alters affinity for ZO-1. For example, the cytoplasmic tails of
many claudins are documented to be phosphorylated at multi-
ple positions including serines, threonines, and tyrosines (15).
Changes in phosphorylation have been correlated with changes
in barrier properties, trafficking, and turnover, cited in Van
Itallie et al. (6), although no direct evidence has yet been pro-
vided that phosphorylation alters affinity of the PDZ domain-
target interaction. Similar correlative findings have been
reported after introducing phosphomimicking mutations (i.e.
mutating the Ser/Thr/Tyr residue to Asp or Glu) although the
mechanisms underlying these changes are not defined (16, 17).
We were particularly interested in testing a role for the tyrosine
at the P6, which we had previously shown could be phosphor-
ylated in vivo (6) and because this position has a tyrosine resi-
due in 9 of the 23 human claudins (Fig. 1).
To better understand the specificity and affinity for the inter-
action of different claudins with ZO-1, we defined the struc-
tural basis for the interaction of ZO-1 PDZ1 with claudin-1,
which lacks Tyr6, and claudin-2, which contains Tyr6. Sur-
prisingly, there are distinct and significant differences between
the way claudin-1 binds PDZ1 and the way claudin-2 binds
PDZ1. Contacts of claudin-2 with the PDZ1 domain include
residues more distal from the C terminus than does claudin-1.
Specifically, the tyrosine residue present in claudin-2 at P6
intercalates between the 2-3 loop of the core PDZ1 domain.
This observation suggested that due to the more extensive
interaction, claudin-2 would bind more tightly than claudin-1
to PDZ1. Isothermal thermal calorimetry and NMR experi-
ments verified this prediction. The functional relevance of the
tyrosine residue was probed by introducing the phosphomim-
icking mutation Y224E (mimicking not the structure of a phos-
phorylated tyrosine, but charge), which revealed that the muta-
tion at this site interrupts in vitro binding to PDZ1 and results
in loss of the claudin-2 barrier properties in cultured MDCK
cells. The modulation of claudin-2 binding to PDZ1 by phos-
phorylation state of Tyr-224 suggests a potential mechanism
for physiologic regulation of affinity. These results can be
applied to a better understanding of the regulation of claudin
function at the tight junction and potentially be generalized to
PDZ-ligand interactions outside the tight junction.
Experimental Procedures
Protein Expression and Purification—For the ZO-1 PDZ1
domain, a DNA fragment encoding for residues 18 –110 of
human ZO-1 was cloned into the NdeI/BamHI sites of a
pET14b expression vector that includes the tobacco etch virus
cleavage site. In addition, the QuikChange site-directed
mutagenesis kit from Agilent Technologies was used to fuse
10-residue extensions to the C terminus of PDZ1 to produce
PDZ1-Cld1 (extension, -GGGSSGKDYV), PDZ1-Cld2 (exten-
sion, -GGGYSLTGYV), and PDZ1-Cld2Y224E (extension,
-GGGESLTGYV). Human claudin tails were cloned into the
NdeI/BamHI sites of a modified pET14b expression vector that
includes a SUMO tag. 13-Residue extensions were thus
inserted to generate the following constructs: His-SUMO-Cld1
(extension, -YPKPAPSSGKDYV), His-SUMO-Cld2 (exten-
sion, -KSEFNSYSLTGYV), and His-SUMO-Cld2Y224E (exten-
sion, -KSEFNSESLTGYV). All recombinant proteins were
expressed in Escherichia coli (BL21 C41). Cells were cultured at
37 °C in 2YT medium then induced by 0.1 mM isopropyl -D-1-
thiogalactopyranoside at 0.6 absorbance (600 nm) and left to
grow overnight at 22 °C. Cells were then harvested by centrifu-
gation at 5000 rpm for 30 min. Pellets were resuspended and
washed with 100 mM KCl, 50 mM Tris-HCl, pH 7.5. Lysis was
accomplished by sonication in a buffer composed of 25 mM
Tris-HCl, pH 7.5, 100 mM KCl, 10% glycerol, 1% Triton X-100,
and 1 mM PMSF. After centrifugation at 30,000 rpm for 1 h, the
FIGURE 1. Sequence alignment of the 10-most C-terminal residues in
human claudins. Humans have 23 annotated claudin (CLDN) genes; CLDN13
is missing in humans; CLD25 has been previously referred to as CLDN21. Of
these 23 human CLDN genes, 15 contain a -YV at the C terminus (highlighted
in yellow). The tyrosine at position 6 (9 of 23) is highlighted in green.
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supernatant was loaded onto a 5-ml His-trap nickel affinity col-
umn (GE Healthcare), and the column was washed with 300 ml
of buffer A composed of 25 mM Tris-HCl, pH 7.5, and 100 mM
KCl supplemented with 25 mM imidazole. Two supplemental
wash steps were performed by flowing 100 ml of buffer A sup-
plemented with (i) 50 mM then (ii) 75 mM imidazole. The bound
protein was then eluted in buffer A supplemented with 500 mM
imidazole. Fractions containing the protein were pooled and
concentrated. All ZO-1 PDZ1 constructs were cleaved using
tobacco etch virus protease, and the cut protein was injected
onto a S-200 gel filtration column (GE Healthcare) equilibrated
with 25 mM Tris-HCl, pH 7.5, 500 mM NaCl, pH 7.5. The purity
of the protein preparations was confirmed using SDS-PAGE
and detected through Coomassie staining. Proteins were con-
centrated to 20 mg/ml (ZO1-PDZ1) and 12 mg/ml (ZO1-
PDZ1-Clds) and stored at 80 °C until used for crystallization
experiments. After elution of the His-trap column, all His-
SUMO-Clds constructs were concentrated and stored at
80 °C until used for calorimetry experiments.
Peptide Synthesis—The acetylated heptapeptides corre-
sponding to the cytoplasmic tail of human claudin-1
(sp_O95832), claudin-2 (sp_P57739), claudin-2 with a phos-
phorylated tyrosine at position 6, and claudin-2Y224E (the
mutated claudin-2 at position 6) were prepared by Biomatik
Corp. (Cambridge, MA). The amino acid composition and
purity (98%) of peptides were verified by mass spectroscopy
and HPLC analysis by the manufacturer.
Isothermal Titration Calorimetry (ITC)—ITC experiments
were performed on a VP-ITC instrument (MicroCal). All ITC
experiments involved direct titration of the His-SUMO ligand
or acetylated peptide ligand into protein solution. PDZ1 (12.5
M) was thus titrated with 5–10-l injections of His-SUMO-
Claudin tails (330 –1600 M) or ac-Cld2 (450 M). All proteins
were dialyzed against the same buffer of 25 mM Tris-HCl, pH
7.5, 500 mm NaCl, and an aliquot of the latter dialysis buffer was
used for dilutions and blank experiments. Experiments were
performed at 25 °C; 5–10-l injections were performed at 200-s
intervals, stirring speed used was 307 rpm, and reference power
was 10 cal/s. The first injection peak was systematically dis-
carded because of the backlash effect of the syringe plunger.
Heats of dilution were measured in blank titrations by injecting
the ligands into buffer and subtracted from the observed raw
heat values. Control experiments were performed and con-
sisted of injecting PDZ1 into buffer and His-SUMO into PDZ1
solution, but these titrations did not produce a significant sig-
nal. Data-fitting was based on a one-site binding model using
the commercial package provided (Origin) to obtain the values
of Kd, H, and S. Each titration was recorded at least in
duplicate.
NMR Experiments—NMR experiments were performed on a
Bruker 900 MHz spectrometer equipped with a cryogenic triple
resonance probe. Experimental conditions were 200 M pep-
tide, 20 M protein in 100 mM PO4, pH 7.2, in 90% 1H2O,
10% 2H2O at 25 °C in 3-mm NMR tubes. The WaterLOGSY
experiments were performed as described previously (18).
The data were collected with a sweep width of 14,370 Hz and
a relaxation delay of 2 s. Water was selectively saturated
using a 2-ms square-shaped pulse with a mixing time of 2 s.
All data were processed by NMRPipe (19) with referencing
to the water peak at 4.773 ppm and using a 4-Hz line-broad-
ening window.
Crystallization—Crystals of the PDZ1-Cld1 and PDZ1-
Cld2Y224E proteins were grown at 20 °C using hanging drop
vapor diffusion against a reservoir containing 20 – 40% PEG
2000 monomethyl ether, 0.1 M sodium acetate (NaAc), pH 4.6,
0.2 M ammonium sulfate, whereas PDZ1-Cld2 protein crystals
where grown at 12 °C against a reservoir containing 2.0 M
sodium formate, 0.1 M NaAc, pH 4.6. Drops of 2.0 l were set up
at a 1:1 ratio of reservoir-to-protein solution at a concentration
of 7–10 mg/ml. Before data collection, crystals were transferred
into a solution containing 80% of the mother liquor, 20% glyc-
erol for cryoprotection.
Data Collection and Structure Solution Determination—Dif-
fraction data for all constructs were collected on the Life Sci-
ences Collaborative Access Team (LS-CAT) ID-G using a
MARCCD 300 detector at a temperature of 100 K and a wave-
length of 0.9785 Å. Data were processed and scaled with XDS
and XSCALE (20). Structures were determined by molecular
replacement with MOLREP (21) using the human ZO1-
PDZ1 structure (PDB entry 2H3M; Ref. 22) as a search
model. Refinement was conducted using REFMAC5 (23) and
model building using Coot (24). The unliganded ZO-1 PDZ1
domain structure was obtained from crystals that contained
the PDZ1-Cld2Y224E fusion protein. Because we did not
observe electron density for the residues corresponding to
the modified claudin-2 tail sequence, we designate this as the
unliganded ZO-1 PDZ1 structure. This 1.9 Å resolution
structure is very similar to the 2.9 Å resolution structure
previously reported (root mean square deviation (r.m.s.d.) of
0.22 Å on 82 atoms with PDB entry 2H3M (22). Non-crystal-
lographic symmetry restraints were not used during refine-
ment. Structural figures were prepared using the PyMol
Molecular Graphics System, Version 1.6.0 Schrödinger,
LLC.
Cell Biology and Physiology Studies—MDCK II Tet-off cells,
cells expressing wild type mouse claudin-2 (25), and () PDZ
binding motif (26) have been previously described. A claudin-2
Y224E mutant was generated using the Agilent QuikChange II
site-directed mutagenesis kit with the following sense primer
(antisense primers are the reverse complement): 5-CAAAGC-
CAAGAGTGAGTTCAACTCAGAAAGCCTGACTGGGT-
3. Stable cell lines were generated as described previously in
Tet-off MDCK II cells. pTRE claudin-2 Y224E vectors were
co-transfected with pTKhyg, and clones were selected by cul-
turing cells in 200 g/ml hygromycin. Two clonal cell lines were
selected and characterized. For all localization and barrier
assays cells were grown on Transwell filters (Corning) for 5
days. Measurement of dilution potential and transepithelial
electrical resistance (TER) was carried out as previously
described (25). Standard SDS-PAGE immunoblotting and
immunofluorescence were carried out as described previously
(26, 27). Claudin and tubulin antibodies were purchased from
Life Technologies; IR-coupled secondary antibodies were from
Rockland (Gilbertsville, PA).
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Results and Discussion
Crystal Structures of the ZO-1 PDZ1 Domain with and with-
out Claudin Ligands—For the purpose of studying the structure
of the human ZO-1 PDZ1 domain in complex with the C ter-
minus of human claudin-1 and -2, we attempted both co-crys-
tallization and soaking methods using heptapeptides corre-
sponding to the respective claudin sequences. However, we did
not observe electron density at the PDZ1 binding region, pre-
sumably due to steric limitations caused by crystal packing.
Therefore, we took advantage of a previously described strategy
in which the claudin C-terminal residues are fused at the C
terminus of the PDZ domain via a tri-glycine linker (22, 28, 29),
such that the residues corresponding to the claudin would bind
to a PDZ1 domain of a neighboring molecule. Using this
approach we determined the crystal structures of the ZO-1
PDZ1 domain in complex with the 7-most C-terminal residues
of claudin-1 (-SSGKDYVCOOH, referred to as PDZ1-Cld1) and
claudin-2 (-YSLTGYVCOOH, PDZ1-Cld2). See Table 1 for
detailed data collection and refinement statistics. In addition,
because we had previously determined by mass spectrometry
that the claudin-2 P6 tyrosine could be phosphorylated in vivo
(6), we crystallized a construct containing PDZ1 followed by a
claudin-2 sequence mutated at P6 with a phosphomimicking
mutation: -ESLTGYVCOOH (PDZ1-Cld2Y224E). However, when
we solved this structure at 1.9 Å resolution, we could not
observe electron density for the claudin-2-related residues and
hence regard this structure as a high resolution unliganded
PDZ1 structure. All comparisons to claudin-1- and -2-bound
PDZ1 complexes are done relative to this high resolution
structure.
Only the Four-most C-terminal Residues of Claudin-1 Make
Contact with the ZO-1 PDZ1 Domain—We determined the
crystal structure of the ZO-1 PDZ1 domain in complex with the
C-terminal residues of human claudin-1 (-SSGKDYV) at a res-
olution of 2.35 Å (Table 1). PDZ1-Cld1 crystallized in the
P41212 space group with two molecules in the asymmetric unit
(depicted in light blue and red, Fig. 2A). The residues corre-
sponding to the claudin-1 C-terminal sequence from one
protomer (e.g. light blue, Fig. 2A) bind to the PDZ1 domain
related by crystallographic symmetry (purple, Fig. 2A). The
PDZ1 domains of the two independent molecules in the asym-
metric unit are essentially identical (r.m.s.d. of 0.29 Å on 86
atoms) as is the conformation of the claudin-1 residues. How-
ever, the precise relative orientation of PDZ1 to claudin-1 dif-
fers between the molecules in the asymmetric unit (Fig. 2B),
made possible by the three glycine residues that link the PDZ1
domain to the claudin-1 sequence. The observed flexibility of
the linker suggests that no artificial constraints (e.g. linker, crys-
tal contacts) determine the precise conformation of the clau-
din-1 residues.
Superimposition of the unliganded and claudin-1-bound
PDZ1 structures reveals that binding of claudin-1 does not gen-
erate a conformational change within the PDZ1 domain
(r.m.s.d. of 0.33 Å on 85 atoms; Fig. 2C). PDZ domains usually
recognize sequences of about three-five residues in length with
a few examples extending to six residues (30). Here we show
that claudin-1 interacts with PDZ1 through its terminal four
amino acids, from Val0 to Lys3 (Fig. 2D and supplemental Fig.
S1). As expected, Val0 makes extensive interactions with PDZ1:
its carboxyl group forms polar contacts with the main chain
atoms of Phe-34 and Gly-35, its side chain orients toward a
hydrophobic area, and its NH atom makes a hydrogen bond
with the carbonyl of Ile-36. The preceding residue, Tyr1, is at
hydrogen bond distance to Asp-58 of PDZ1, but otherwise lacks
extensive hydrophobic interactions. The side chain of Tyr1
also interacts with the side chain of Lys3. Farther away from
the claudin-1 C terminus, Asp2 makes main chain hydrogen
bond contacts with Ile-38 and through its side chain builds a
polar contact with the side chain of His-88. Finally, the side
chain of Lys3 makes a hydrogen bond with the main chain of
Ser-57 as well as the aforementioned interaction with Tyr1.
Most relevant to our understanding of the interaction between
claudin-1 and the PDZ1 domain, the claudin-1 residues beyond
Lys3 are not observed to make any direct interaction with the
PDZ1 domain.
Seven C-terminal Residues of Claudin-2 Make Contact with
the ZO-1 PDZ1 Domain—Next we determined the structure of
the PDZ1 domain in complex with human claudin-2 (-YSLT-
GYV) at a resolution of 1.79 Å (Table 1). PDZ1-Cld2 crystal-
lized in the P212121 space group and displays 2 molecules in the
asymmetric unit. As observed for PDZ1-Cld1, the C-terminal
claudin-2 residues bind to an adjacent crystallographically
TABLE 1
Data collection and refinement statistics
a.u., asymmetric unit.
PDZ1 PDZ1-Cld1 PDZ1-Cld2









Observed 59,341 (9,444) 95,219 (14,861) 162,977 (13,612)
Unique 24,585 (3,900) 13,306 (2,056) 22,067 (3,348)
Completeness (%) 95.1 (94.2) 99.6 (99.2) 99.2 (95.1)
Rsym (%) 2.8 (44.8) 5.8 (65.1) 7.7 (59.2)
Average I/(I) 17.5 (2.7) 29.3 (3.4) 16.8 (2.3)
Redundancy 2.4 (2.4) 7.1 (7.2) 7.4 (4.1)
Space group C2 P41212 P212121
Unit cell (Å): a, b, c 104.9, 60.4, 62.2 106.2, 106.2, 53.9 41.3, 72.2, 76.9
, ,  90.0, 124.2, 90.0 90, 90, 90 90, 90, 90
Refinement statistics
Rcryst (%) 19.5 (34.3) 21.4 (35.1) 19.8 (35.7)
Rfree (%) 24.3 (39.3) 25.6 (32.2) 25.3 (42.9)
Resolution range (Å) 51.42–1.90 75.12–2.35 52.64–1.79
Protein molecules per a.u. 3 2 2
Number of atoms
Protein 2,037 1,543 1,597
Water molecules 96 43 187
SO4
 10




Bond length (Å) 0.012 0.012 0.013
Bond angles (°) 1.558 1.688 1.561
Average B-factors (Å2)
Protein 36.6 47.7 13.9
Water molecules 38.9 49.6 30.7
SO4
 38.3








Generously allowed 0.9 1.2 0.0
Disallowed regions 0.0 0.0 0.0
a The last shell is in parentheses.
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related PDZ1 domain. Unliganded PDZ1 and PDZ1-Cld2 were
superimposed (r.m.s.d. of 0.38 Å on 77 atoms; Fig. 3A). Notably
different from the case observed with claudin-1 binding to
PDZ1, the binding of claudin-2 involves a main chain confor-
mational change within the 2:3 loop of the PDZ1 domain
(Fig. 3B, red arrow). Unbiased electron density for the 2:3
loop in the apo- and claudin-2-bound state is shown in Fig. 3, C
and D, respectively (see also supplemental Fig. S2). Indeed,
Tyr6 intercalates in the 2:3 loop (Fig. 3, E and F), which
requires a major conformational change of residues His-46 and
Phe-47 of PDZ1 to avoid a steric clash (Figs. 3B). Residues Val0
and Tyr1, common to both claudin-1 and -2, interact with
PDZ1 in a similar manner. However, the main chain of Tyr1 in
claudin-2 makes an extra interaction with the side chain of
Arg-96 from PDZ1 (Fig. 3E). This interaction is made possible
by the presence of a glycine residue at P2 of claudin-2; any
larger claudin residue at that position (it is an Asp in claudin-1)
would sterically block the extension of the PDZ1 Arg-96 side
chain, the conformation required for interaction with Tyr1.
The aforementioned Gly2 interacts via its main chain NH and
carbonyl atoms with the carbonyl and NH atoms of Ile-38,
respectively. The preceding residue in claudin-2, Thr3,
employs its side chain to hydrogen bond with the Ser-39 side
chain, whereas the Leu4 main chain NH and carbonyl atoms
make polar contacts with Asn-44 (Fig. 3E). Finally, although
Ser5 faces away from the PDZ1 domain, Tyr6 inserts in the
2:3 loop where it is stabilized by hydrophobic interactions
(Fig. 3F). A previous study using phage display to identify high
affinity peptide ligands of the ZO-1 PDZ1 domain revealed that
the best binders have a hydrophobic residue (tryptophan or
tyrosine) at P6 that intercalates in the 2:3 loop (22), a fea-
ture we also observe with the physiologically relevant claudin-2
FIGURE 2. Claudin-1 (Cld1) uses its 4-C-terminal residues to bind to the ZO-1 PDZ1 domain, which does not undergo any significant conformational
change upon Cld1 binding. A, the C-terminal sequence of Cld1 was fused to C terminus of PDZ1 (see “Experimental Procedures”). The two PDZ1-Cld1
molecules in the asymmetric unit are represented in light blue and red. The Cld1 tail from one molecule (light blue) binds at the PDZ binding site of a
crystallographically related molecule (purple). B, the two PDZ1-CLD1 molecules in the asymmetric unit are overlaid showing the different orientations of the
Cld1 peptides. C, overlay of unliganded PDZ1 (green) on the PDZ1-Cld1 complex reveals no conformational change in PDZ1 upon ligand binding. D, detailed
view of the PDZ1-Cld1 interaction. Hydrogen bond interactions are denoted with a dashed line. An Fo  Fc omit map (gray mesh) contoured at 2.0  around Cld1
peptide is also shown. Cld1 peptide was removed from the model that then underwent several rounds of refinement to eliminate model bias.
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sequence (Fig. 3G). To summarize the structural results, the
PDZ1-Cldn2 complex structure reveals extended interactions
to the PDZ1 domain that include the interaction of Tyr6 with
the 2:3 loop. This is in contrast to the interaction with clau-
din-1, which is limited to residues between P2 and P0.
Calorimetric Measurements—The more extended interac-
tion between claudin-2 and PDZ1 relative to that formed by
claudin-1 suggest that the binding affinity between PDZ1 and
claudin-2 would be greater than that between PDZ1 and clau-
din-1. To test this prediction we used ITC to determine the
affinities of claudin peptides to ZO-1 PDZ1 (Table 2, Fig. 4). To
provide the high concentrations of peptide required for titra-
tion, we generated and expressed in E. coli constructs in which
the claudin-1, -2, and -2Y224E C-terminal sequences are fused to
a His-SUMO tag (see “Experimental Procedures” for details).
Titrations of claudin peptides (in the context of fusions to His-
SUMO) into PDZ1 as well as the experimental fits are given in
Fig. 4. Satisfactory titrations to saturation could be performed
only for the claudin-2 peptide (Fig. 4A) with a measured Kd of
13.5 M (Table 2), which is consistent with affinity measured
by Zhang et al. (13 M; Ref. 14) using a different method. The
same binding experiment was conducted using an N-terminal-
acetylated peptide corresponding to the last seven residues of
claudin-2 (acCld2: -acYSLTGYV), and equivalent values were
obtained (Table 2, Fig. 4B), thus indicating that the His-SUMO
tag is not contributing or otherwise affecting the interaction
with PDZ1. In contrast to these claudin-2 binding studies, we
were not able to reach saturation upon titration of His-SUMO-
Cld1 peptide into PDZ1 under the experimental conditions
(Fig. 4C), indicating a very low binding affinity. Interestingly,
the same lack of binding as observed with claudin-1 was
obtained with claudin-2 when tyrosine at P6 is mutated into
the phosphomimetic amino acid (Glu) (Fig. 4D), indicating that
phosphorylation at this position would considerably lower the
affinity to PDZ1.
NMR Measurements—We have previously shown that
WaterLOGSY NMR is useful for the detection of peptide inter-
actions with larger proteins (12). We thus performed Water-
LOGSY experiments to detect claudin peptide binding to the
ZO1 PDZ1 domain by monitoring the acetyl group present in
each peptide. In the WaterLOGSY experiment, the presence of
positive resonances occurs when a small molecule such as a
peptide binds to a larger biomolecule (18). As shown in Fig. 5A,
we observed binding of claudin-2 to PDZ1. On the other hand,
we observed little or weak binding of claudin-1 to PDZ1 (Fig.
5B). When we exchanged the Ser6 residue in claudin-1 by a
tyrosine we could detect binding to PDZ1 (Fig. 5C). Conversely,
when we mutated the Tyr6 residue in claudin-2 to a glutamic
acid (generating the phosphomimic) or when using a phospho-
tyrosine-containing peptide the previously strong binding sig-
nal was largely diminished (Fig. 5, D and E, respectively). Hence,
the NMR studies corroborate the calorimetry results that clau-
din-2 binds more tightly than claudin-1 to the ZO-1 PDZ1
domain. Additionally, the NMR data shows that the unphos-
phorylated claudin-2 peptide binds more tightly than its phos-
phorylated version or its Y224E phosphomimic version. Fur-
thermore, it shows that adding a tyrosine to a claudin that
naturally lacks this type of residue at position P6 can enhance
binding. Note that the lack of observed binding of wild type
claudin-1 to PDZ1 in this NMR experiment and in the ITC
experiment does not mean that it does not bind in cells; it only
means that this interaction in isolation and under the experi-
mental conditions is not detectable, so we can only make con-
clusions as to relative affinities. Because claudins are oligomeric
and ZO-1 is at least a homodimer, avidity would greatly
increase the affinity in the natural membrane proximity where
the interaction between claudins and ZO proteins occurs.
A Phosphorylation-mimicking Y224E Mutation of Claudin-2
Results in Loss of Its Physiologic Barrier Properties and
Decreased Claudin-2 at the Junction—Our structural and bio-
chemical results demonstrate that interaction of Tyr-224 (i.e.
Tyr6) of claudin-2 with the 2:3 loop of the PDZ1 domain of
ZO-1 is critical for creating high affinity binding. We previously
showed using mass spectrometry that Tyr-224 can be phosphor-
ylated in MDCK-cultured epithelial cells, although at steady
state in confluent monolayers the level is very low (6). Taken
together with the structural studies described above leads to
speculation that the phosphorylation state at this position
might be a physiologic mechanism for modulating the affinity
for ZO-1, with possible functional consequences. Claudin-2
normally creates pores through the tight junction with low TER
and high Na permeability (25, 31). Hence, disruption of clau-
din-2 function is predicted to result in increased TER and
decreased Na permeability. To test the possibility that phos-
FIGURE 3. Claudin-2 (Cld2) uses its seven C-terminal residues to bind to the ZO-1 PDZ1 domain, which as a result undergoes a significant conforma-
tional change in its 2-3 loop. A, overlay of unliganded PDZ1 (green) on the PDZ1-Cld2 complex (PDZ1 in yellow, Cld2 residues in brown). Note the
conformational change of the 2-3 loop. B, zoom on the 2-3 loop. In addition to a change in main chain atoms of the entire loop, most dramatic is the
change in position of the His-46 –Phe-47 side chains. The red arrow demonstrates the conformational change. C, Fo  Fc omit map (gray mesh) contoured at 2.0
 around unliganded PDZ1 2-3 loop. D, Fo  Fc omit map (gray mesh) contoured at 2.0  around PDZ1-Cld2 2-3 loop. E, detailed view of the PDZ1-Cld2
interaction. Hydrogen bond interactions are denoted with a dashed line. Fo  Fc omit map (gray mesh) contoured at 2.0  around Cld2 peptide is also shown.
Cld2 peptide was removed from the model that then underwent several rounds of refinement to eliminate model bias. F, surface representation of PDZ1 with
hydrophobic surfaces colored in magenta. Note how Tyr6 buries its side chain into the area previously occupied by the 2-3 loop. G, stereoview of the
overlay of unliganded PDZ1 (green), Cld2-bound PDZ1 (yellow for PDZ1, brown for Cld2), and PDZ1 in complex with a tight binding peptide identified via phage
display (orange). The P6 tryptophan residue present in the phage display sequence binds in a similar manner to the Cld2 Tyr6. As seen for PDZ1-Cld2, the
2-3 loop adjusts its position to accommodate the tryptophan side chain. This suggests that high affinity binders utilize a P6 residue (Tyr or Trp) that
displaces the 2-3 loop and buries its side chain in the ensuing cavity.
TABLE 2
Calorimetric analysis of PDZ1/claudin peptides interactions from ITC
measurements
Peptide Na Kd H 	S
M kcal/mol kcal/mol
His-SUMO-Cld1 NDb ND ND ND
His-SUMO-Cld2 1.1  0.1 13.5  1.3 6808  681.6 166.9
His-SUMO-Cld2-Y224E ND ND ND ND
ac-Cld2 1.0  0.1 16.6  1.3 6265  853.9 256.3
a Stoichiometry.
b ND, not detectable under the experimental conditions.
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phorylation of Tyr-224 alters claudin-2 function, we generated
clonal monolayers of MDCK II cells expressing the phosphor-
ylation-mimicking Y224E mutant of claudin-2 under an induc-
ible promoter and determined the effect on barrier properties
and cellular localization before and after induction. For com-
parison, we also determined the effects of expressing previously
described wild type claudin-2 (25) and a form of claudin-2 in
which the terminal three residues were removed (3) making it
incapable of binding PDZ1 (6).
Expression of all three forms of claudin-2 could be induced in
MDCK monolayers as determined by immunoblotting (Fig.
6A). When additional wild type claudin-2 is induced, as previ-
ously shown (25), there is no change from the normally low
monolayer resistance and high Na permeability (Fig. 6B, left
bars). In contrast, when the Y224E mutant is induced there is a
highly significant doubling in the electrical resistance (Fig. 6B,
middle bars) and a decrease in the dilution potential both
accounted for a specific decrease in Na permeability (Fig. 6C,
middle bars). The same electrophysiological phenotype is
observed when the (3) mutant is expressed (Fig. 6, B and C,
right bars). This is the predicted outcome if there is less func-
tional claudin-2 in the tight junction.
A decreased level of claudin-2 at the tight junction was con-
firmed by confocal immunofluorescent imaging (Fig. 7). ZO-1
was used to define the location of the tight junction in z-axis
confocal images. The localization of ZO-1 (green) and endoge-
nous claudin-2 (red) normally coincides resulting in a yellow
merged localization (Fig. 7, top row). When additional wild type
claudin-2 was induced the continuous junctional colocalization
(yellow) intensifies. There is also a small accumulation of
claudin-2 in intracellular vesicles (Fig. 7, second row). In con-
trast, when expression of the Y224E mutant is induced there
is less claudin-2 at the junction, and it is less continuous. The
merged junctional signal becomes greener, indicating that
the ratio of claudin-2 to ZO-1 at the junction has decreased
(Fig. 7, bottom row). There is also a visible increase in the
relative amount of claudin-2 in vesicles. The antibody used
recognizes both the wild type and Y224E forms of claudin-2.
Removal of wild type claudin-2 from the junction was also
observed after inducing expression of claudin-2 lacking its
C-terminal three residues (data not shown).
Taken together we interpret these data as indicating that
when the affinity of claudin-2 for PDZ1 is lowered by the
phosphorylation-mimicking mutation, Cld2Y224E, or when
FIGURE 4. ITC measurements for PDZ1/claudin peptides interactions. Shown are titration data of His-SUMO-Cld2 peptide (A), acetylated Cld2 peptide (B),
His-SUMO-Cld1 peptide (C), and His-SUMO-Cld2-Y224E peptide (D) injected into PDZ1 and the integrated heat measurements for the titration corrected from
the reference (see “Experimental Procedures”). The measured thermodynamic parameters are reported in Table 2.
FIGURE 5. Detection of claudin peptide binding to PDZ1 by NMR. PDZ1 was added to the peptide solution, and WaterLOGSY was used to detect binding.
Shown is the acetyl resonance used as a reporter. In this type of experiment the relative height of the signal reflects the degree of binding. Note the strong
signal for Cld2 (i.e. strong binding) (A) and lack of signal for Cld1 (i.e. weak binding) (B). C, Cld1 binding could be detected when Ser-205 at P6 is replaced by
a tyrosine. D, the phosphomimetic Cld2-Y224E peptide shows decreased binding relative to Cld2. E, likewise, the phosphotyrosine-containing peptide shows
decreased binding relative to the unphosphorylated form.
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the C-terminal three residues of the PDZ binding motif are
removed Cld2(3), its physiologic influence as a pore is
diminished, possibly through a change in trafficking that
results in accumulation in vesicles. We previously showed
that claudin-2 forms dimers in MDCK cells (32). We specu-
late that the mutant forms of claudin-2 bind wild type endog-
enous claudin-2 resulting in its coincident defective target-
ing. These results are consistent with a model that has the
phosphorylation state of Tyr6 acting as a modulator of
claudin-2 function, specifically, by influencing its affinity
(high, non-phosphorylated; low, phosphorylated) to the
ZO-1 PDZ1 domain.
Role of the 2-3 Loop of PDZ Domains in Ligand Binding
Affinity—The canonical binding of C-terminal protein
sequences by PDZ domains involves a binding site relatively
distant from the PDZ domain 2-3 loop. Therefore, it is not
surprising that for most PDZ domains, binding of their partic-
ular protein target does not impact the conformation of this
loop. Indeed, this is also the case we observe when claudin-1
binds PDZ1; the 2-3 loop is unperturbed relative to its unli-
ganded state (Fig. 8A). Surprisingly, this is not the case upon the
binding of claudin-2 by this same PDZ domain. In this case, a
significant conformation change of the 2-3 loop occurs,
which is presumably induced by Tyr6 that buries itself in the
space previously filled by this loop (Fig. 8B). This is not the first
example for a change in the 2-3 loop conformation upon
ligand binding. Recently it was shown that the Tax-interacting
protein-1 (TIP1) undergoes a conformational change in its 2-
3 loop upon binding of ligand -catenin (Fig. 8C) (33). In the
case of -catenin binding to TIP1, it is its tryptophan residue at
P5 that displaces the 2-3 loop of the TIP1 PDZ domain.
Notably, the P5 tryptophan residue occupies a very similar
position as the P6 tyrosine residue of claudin-2 when bound to
the ZO-1 PDZ1 domain (Fig. 8D). An additional commonality
to our result with claudin-2 showed that mutation of the tryp-
tophan (in the case to an alanine) reduces the binding affinity by
100-fold (33). A similar change in the PDZ 2-3 loop confor-
mation between the unbound and its ligand-bound state was
observed with the PDZ of SHANK1 (34). Hence, it appears that
the intrinsic flexibility of the 2-3 loop present in certain PDZ
binders (such as TIP1, SHANK1, and ZO-1 PDZ1) is exploited
for attaining increased binding affinity. However, unlike TIP1
and SHANK1, where the ligands (-catenin and ARHGEF7,
respectively) insert a tryptophan residue, claudin-2 binding to
PDZ1 utilizes a tyrosine residue. This is an important distinc-
tion, as Tyr6 can be phosphorylated, and this posttranslational
FIGURE 6. The tyrosine phosphomimic mutant Y224E affects the TER and dilution potential in MDCK monolayers relative to the wild type. A, inducible
expression of claudin-2 (Cld2), the Y224E phosphomimic (Cld2Y224E) and a three-residue C-terminal truncation variant (Cld2(3)). Immunoblot analysis dem-
onstrates inducible expression of the three claudin forms in representative clonal monolayers (U 
 uninduced; I 
 induced). B, induction of the wild type
claudin-2 results in no change in TER, whereas expressing either the Y224E or (3) mutants result in a significant increase in TER. C, induction of the wild type
claudin-2 results in no change in dilution potential, whereas expressing either the Y224E or (3) mutants results in a significant decrease. Data represent the
means  S.E. of determinations from duplicate Snapwells for wild type claudins and mutants. Significance was calculated using Student’s t test.
FIGURE 7. The tyrosine phosphomimic mutant Y224E fails to localize to
tight junctions and reduces the wild type claudin-2 at the junction.
Shown is confocal immunofluorescence localization ZO-1 (green), claudin-2
(red), and merged imaged (yellow) before and after induction of Cldn2WT and
Cldn2Y224E. ZO-1 and endogenous and induced Cldn2WT are well colocalized
at the junction (top two rows). In contrast, induction of Cldn2Y224E (bottom
row) resulting in less continuous claudin-2 staining and a shift from yellow to
green in the merged image is shown.
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modification can be used to modulate the affinity and hence the
function of claudin-2.
The above analysis shows that ligand affinity to PDZ is
increased by the presence of a large hydrophobic residue (Trp
or Tyr) at P5 or P6. But is the ability to modulate this affinity
by changing the phosphorylation state of Tyr6 unique to clau-
din-2 or a general principal exploited by claudins and possibly
other PDZ binders? While an open question, we note that a very
recent study of claudin-3, which also has a Tyr6 (Tyr-214),
shows that mutation of that tyrosine to an aspartic acid (i.e. a
phosphomimetic) perturbs claudin-3 trafficking to junctions
and thereby decreases junctional dynamics (17). In another
study, increased phosphorylation of the claudin-3 Tyr-214 was
detected in epidermal growth factor receptor- and c-MET-pos-
itive colon cancer (35). The disruption of barrier function is
often observed in cancers, and our data suggest that the
detected observed phosphorylation of claudin-3 Tyr-214 would
diminish its affinity to the ZO-1 PDZ domain.
FIGURE 8. Role of PDZ domain 2-3 loop flexibility in ligand affinity. A, overlay of the unliganded ZO-1 PDZ1 domain (green) and Cld2-bound PDZ1 (PDZ1
in purple, Cld1 in light blue). The 2-3 loop does not change conformation nor participates in ligand binding when Cld1 binds PDZ1. B, in contrast, the 2-3
loop does change conformation and does participate in ligand binding when Cld2 binds PDZ1 (PDZ1 in yellow, Cld1 in brown). Cld2 inserts Tyr6 into the space
previously occupied by the 2-3 loop. C, a similar change in the 2-3 loop PDZ conformation (represented by a white arrow) was observed for TIP1
(unliganded shown in magenta) when bound to -catenin (complex in orange). D, focus on Cld1/Cld2/-catenin binding to the PDZ domain (PDZ domains
shown as transparent objects). Cld2 makes a similar binding mode as -catenin, where Tyr6 or Trp5, respectively, insert into the space vacated by the 2-3
loop.
FIGURE 9. Sequence alignment of PDZ1 from human ZO-1, 2, and -3 shows large conservation except for the 2-3 loop region in ZO-3. 2-3 loop
residues in ZO-1 are highlighted in green. The His-Phe residues within the 2-3 loop, in which side chains dramatically change in position are highlighted in
gray. The residues missing in ZO-3 are highlighted in red. Stars denote conserved, colons highly homologous, and a period moderately homologous residues.
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Looked upon from a different perspective, it was shown that
ZO-3 is unable to restore claudin assembly into tight junction
strands in cells lacking ZO-1 and ZO-2 (3). Sequence analysis
indicates that there is a notable difference in the 2-3 loop of
ZO-3 relative to the other ZO proteins; specifically, there is a
5-residue deletion and loss of the consecutive His-Phe
sequence that we identified as playing an important role in
Tyr6 binding (Fig. 9). While requiring confirmation by addi-
tional experiments, our data suggest that the inability of ZO-3
to compensate for the lack of ZO-1 and ZO-2 stems from the
inability of its PDZ1 domain from forming the high affinity
interaction with Tyr6-containing claudins.
In summary, our studies, presenting the first crystal struc-
tures of claudins binding to the ZO-1 PDZ1 domain, reveal
divergent binding modes between claudin-1 and -2. The molec-
ular explanation for the higher PDZ1 affinity of claudin-2 is the
presence of Tyr6, which forms interactions not present in the
case of claudin-1 binding. This interaction is made possible by
the intrinsic flexibility of the 2-3 loop. Moreover, we show
that phosphorylation of this residue can be exploited to reduce
the affinity to PDZ1. Hence, we suggest that this is one possible
mechanism used by the large subset of claudins that possesses a
Tyr6 for regulating their localization at the tight junction and
perhaps a more general mechanism exploited by PDZ binders
for controlling their binding affinity.
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